Who owns Corcept Therapeutics Incorporated?

Key details on Corcept Therapeutics Incorporated (Ticker: CORT)

Who owns Corcept Therapeutics Incorporated?

Is CORT a good stock to own? Find out who bought Corcept Therapeutics Incorporated, who sold Corcept Therapeutics Incorporated (CORT) stock, and who holds a large position in Corcept Therapeutics Incorporated.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.21M $39.64M Dec. 31, 2014
TimesSquare Capital Management 4.10M $11.45M Sept. 30, 2012
Investor AB 3.45M $10.36M Dec. 31, 2014
Credit Suisse AG 2.73M $7.61M Sept. 30, 2012
BlackRock Institutional Trust Company, N.A. 2.39M $7.18M Dec. 31, 2014
Vanguard 2.20M $6.61M Dec. 31, 2014
Jennison Associates 2.15M $9.38M March 31, 2014
BlackRock Fund Advisors 1.49M $4.48M Dec. 31, 2014
MORGAN STANLEY 1.47M $0 Dec. 31, 2014
First Eagle Investment Management 991978 $3.19M Dec. 31, 2013
STATE STREET CORPORATION 962289 $2.89M Dec. 31, 2014
TCW 718786 $1.03M Dec. 31, 2012
Adage Capital Partners GP 655984 $1.13M June 30, 2013
NORTHERN TRUST 573701 $1.72M Dec. 31, 2014
Catalyst Capital Advisors 540000 $1.45M Sept. 30, 2014

Who sold Corcept Therapeutics Incorporated?

Fund Name Date Sold Number of Shares Sold Share Valuation
Bridger Management Sept. 30, 2011 559218 $1.73M
Franklin Resources March 31, 2011 988800 $4.20M
Ayer Capital Management March 31, 2011 657000 $2.79M
Maverick Capital June 30, 2008 584763 $1.15M